Acute Appendicitis — Preoperative Immature Granulocyte Count and Percentage for Acute Appendisitis
Citation(s)
Ayres LS, Sgnaolin V, Munhoz TP Immature granulocytes index as early marker of sepsis. Int J Lab Hematol. 2019 Jun;41(3):392-396. doi: 10.1111/ijlh.12990. Epub 2019 Feb 26.
Collard M, Lakkis Z, Loriau J, Mege D, Sabbagh C, Lefevre JH, Maggiori L Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis. J Visc Surg. 2020 Jun;157(3S1):S33-S42. doi: 10.1016/j.jviscsurg.2020.04.014. Epub 2020 Apr 24.
Hogan A COVID-19 and emergency surgery. Br J Surg. 2020 Jun;107(7):e180. doi: 10.1002/bjs.11640. Epub 2020 Apr 24. No abstract available.
Jha P, Espinoza N, Webb E, Kohli M, Poder L, Morgan T Single institutional experience with initial ultrasound followed by computed tomography or magnetic resonance imaging for acute appendicitis in adults. Abdom Radiol (NY). 2019 Jul;44(7):2357-2365. doi: 10.1007/s00261-019-01998-1.
Kelly ME, Murphy E, Bolger JC, Cahill RA COVID-19 and the treatment of acute appendicitis in Ireland: a new era or short-term pivot? Colorectal Dis. 2020 Jun;22(6):648-649. doi: 10.1111/codi.15141. Epub 2020 May 31. No abstract available.
Kim HY, Park JH, Lee SS, Lee WJ, Ko Y, Andersson RE, Lee KH CT in Differentiating Complicated From Uncomplicated Appendicitis: Presence of Any of 10 CT Features Versus Radiologists' Gestalt Assessment. AJR Am J Roentgenol. 2019 Nov;213(5):W218-W227. doi: 10.2214/AJR.19.21331. Epub 2019 Aug 15.
Kirkil C, Yigit MV, Aygen E Long-term results of nonoperative treatment for uncomplicated acute appendicitis. Turk J Gastroenterol. 2014 Aug;25(4):393-7. doi: 10.5152/tjg.2014.7192.
Park JS, Kim JS, Kim YJ, Kim WY Utility of the immature granulocyte percentage for diagnosing acute appendicitis among clinically suspected appendicitis in adult. J Clin Lab Anal. 2018 Sep;32(7):e22458. doi: 10.1002/jcla.22458. Epub 2018 Apr 30.
Soh JS, Lim SW Delta neutrophil index as a prognostic marker in emergent abdominal surgery. J Clin Lab Anal. 2019 Jul;33(6):e22895. doi: 10.1002/jcla.22895. Epub 2019 Apr 15.
Unal Y A new and early marker in the diagnosis of acute complicated appendicitis: immature granulocytes. Ulus Travma Acil Cerrahi Derg. 2018 Sep;24(5):434-439. doi: 10.5505/tjtes.2018.91661.
Xu Y, Jeffrey RB, Chang ST, DiMaio MA, Olcott EW Sonographic Differentiation of Complicated From Uncomplicated Appendicitis: Implications for Antibiotics-First Therapy. J Ultrasound Med. 2017 Feb;36(2):269-277. doi: 10.7863/ultra.16.03109. Epub 2016 Dec 31.
Yazar FM, Urfalioglu A, Bakacak M, Boran OF, Bulbuloglu E Efficacy of the Evaluation of Inflammatory Markers for the Reduction of Negative Appendectomy Rates. Indian J Surg. 2018 Feb;80(1):61-67. doi: 10.1007/s12262-016-1558-y. Epub 2016 Oct 18.
Preoperative Immature Granulocyte Count and Percentage for Complicated and Uncomplicated Appendisitis
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
